Proseek Bio
PrivateLast Round
Seed
Apr 8, 2026
Total Funding Raised
$1.06M
Company Overview
Proseek Bio is a biotechnology company that develops non-invasive, multi-biomarker blood tests for women's health, focusing on early detection of ovarian cancer using a proprietary glycoproteomics mass spectrometry platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proseek Bio Comparables
Compare Proseek Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyOncoDx, Inc. | 84% | |
| InterVenn Biosciences | 84% | |
| CpG Diagnostics, Inc. | 83% | |
Proseek Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 8, 2026 |
Proseek Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scale Investors | Seed |
| Angel Loop | Seed |
Proseek Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Proseek Bio's valuation, stock price, and market status.